home / stock / tnxp / tnxp news


TNXP News and Press, Tonix Pharmaceuticals Holding Corp. From 08/04/22

Stock Information

Company Name: Tonix Pharmaceuticals Holding Corp.
Stock Symbol: TNXP
Market: NASDAQ
Website: tonixpharma.com

Menu

TNXP TNXP Quote TNXP Short TNXP News TNXP Articles TNXP Message Board
Get TNXP Alerts

News, Short Squeeze, Breakout and More Instantly...

TNXP - Watch for Continued Gains in Shares of Tonix Pharmaceuticals Holding Corp. (TNXP)

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) traded today at a new 52-week high of $1.72. So far today approximately 325,000 shares have been exchanged, as compared to an average 30-day volume of 19.1 million shares. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is currently pri...

TNXP - Best Penny Stocks To Buy Now? 4 Monkeypox Stocks To Watch This Week

Monkeypox stocks are beginning to capture broad market attention, and, yes, penny stocks are among the most speculated upon. But there are a few things you have to understand when approaching this niche. Like COVID stocks, more assumptions are being made about “what might happen&...

TNXP - Biden names top officials to lead monkeypox response as more states cites emergencies

President Joe Biden appointed two top federal officials to lead the U.S. response against monkeypox, the White House announced Tuesday, as the ongoing outbreak has prompted more states to declare emergencies to contain the virus. Robert Fenton, who currently serves as Regional Admin...

TNXP - Tonix gets federal grant to develop TNX-1300 for treating cocaine intoxication

Tonix Pharmaceuticals ( NASDAQ: TNXP ) received a grant from the  National Institutes of Health (NIH) to support development of TNX-1300 for treating cocaine intoxication. The company said TNX-1300 is a recombinant enzyme which efficiently degrades and metabolizes...

TNXP - Tonix Pharmaceuticals Receives Federal Grant from the National Institute on Drug Abuse (NIDA) to Advance Development of TNX-1300 as a Treatment for Cocaine Intoxication

There is No FDA-Approved Product for Cocaine Intoxication TNX-1300 Has Been Granted Breakthrough Therapy Designation by the FDA Phase 2 Single-Blind, Placebo-Controlled, Potential Pivotal Study Expected to Start in Fourth Quarter 2022, Pending FDA Agreement CHATHAM...

TNXP - Best Penny Stocks to Watch Before Market Open on August 2nd 

Buying Penny Stocks on August 2nd? Here’s What You Need to Know If you’re looking for penny stocks to buy, there are hundreds of options to choose from. But, with so many stocks to choose from, how do you know which ones are worth investing in? There are a few things you s...

TNXP - Tonix Pharmaceuticals (TNXP) Stock Surges 15% on Patent News

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clinical-stage biotechnology firm Tonix Pharmaceuticals (NASDAQ: TNXP ) – which focuses on novel therapeutics and diagnostics – is making waves today, announcing the issuance of a patent . Specifically,...

TNXP - Shares of Tonix Pharmaceuticals Holding Corp. (TNXP) Rise to a New 52-Week High

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) traded at a new 52-week high today of $2.13. So far today approximately 1.5 million shares have been exchanged, as compared to an average 30-day volume of 19.1 million shares. Tonix Pharmaceuticals Holding Corp. share prices have moved be...

TNXP - Monkeypox plays rally as New York calls outbreak a public emergency

Companies focused on developing solutions against monkeypox jumped in the pre-market Monday after New York became the second major U.S. city to call the current outbreak a public health emergency. Announcing the decision on Saturday, New York Mayor Eric Adams and Dr. Ashwin Vasan, c...

TNXP - Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering Potentiated Intranasal Oxytocin (TNX-1900) for the Treatment of Pain

New patent expected to expire in 2036 Phase 2 Study for Prevention of Migraine Headache Expected to Start Second Half 2022 CHATHAM, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, annou...

Previous 10 Next 10